Drug intelligence / Profile preview

lactoferrin + probiotics

Development stage: Unknown
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Recombinant Proteins and Enzymes, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

**Lactoferrin + probiotics** is a combination dietary supplement designed to support gastrointestinal and immune health. Lactoferrin is a multifunctional iron-binding glycoprotein found in milk and other secretions, known for its antimicrobial and immunomodulatory activities. Probiotics are live microorganisms, typically species of Lactobacillus and Bifidobacterium, that provide health benefits by supporting or restoring species diversity in the gut microbiota. Together, these agents are used primarily to promote gut health, improve digestion, prevent and manage diarrhea, relieve flatulence and bloating, support immune function, and may prevent or manage gastrointestinal conditions such as irritable bowel syndrome (IBS) and necrotizing enterocolitis (NEC) in premature infants. The combination may offer additive or synergistic benefits, especially in reducing the risk of gastrointestinal infections and sepsis by modulating gut flora and enhancing mucosal immunity[1][3][4].

Targets

LbpB (Lactoferrin-binding protein B)OmpC (Outer membrane porin C)PhoE (Outer membrane porin PhoE)

Beyond the preview

Go deeper on lactoferrin + probiotics.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lactoferrin + probiotics.

Explore the full profile